BEAT BioTherapeutics
Recent Finacing
Seed
Recent Raise
$2.5M
BEATBio is a Seattle biotech developing a gene therapy that increases a native enzyme to enhance cardiac contractility and relaxation, holding University of Washington licenses and pursuing clinical development.
Highlights
Focus Areas
Biotechnology
Medical
Therapeutics
Recent Investors
Financials
$2.5M
Total Raised
1
Funding round
2
Investors